BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9738360)

  • 1. [Pharmacologic therapy of cranio-cervico-mandibular disorders. Review of the literature].
    Catapano S; Gavagna M; Baldissara S; Baldissara P
    Minerva Stomatol; 1998 Jun; 47(6):265-71. PubMed ID: 9738360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic treatment of the dysfunctional patient.
    Cardelli P; Lattari M; Massaro P; Pollicita M; Barlattani A
    Minerva Stomatol; 2005 May; 54(5):265-79. PubMed ID: 15985981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myoarthropathy of the temporomandibular joint and masticatory muscles. Pain therapy management and relaxation instead of aggressive surgery].
    Türp JC
    MMW Fortschr Med; 2003 May; 145(19):33-5. PubMed ID: 12813975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic management of temporomandibular disorders.
    Hersh EV; Balasubramaniam R; Pinto A
    Oral Maxillofac Surg Clin North Am; 2008 May; 20(2):197-210, vi. PubMed ID: 18343325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment protocol for craniomandibular dysfunction 2. Treatment].
    Naeije M; Lobbezoo F; van Loon LA; Savalle WP; van der Zaag J; Huddleston Slater JJ; van der Meulen MJ; Visscher CM
    Ned Tijdschr Tandheelkd; 2000 Oct; 107(10):406-12. PubMed ID: 11383233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical aspects of cranio-mandibular disorders. II. Symptom profiles of subgroups].
    Capurso U
    Minerva Stomatol; 1996; 45(7-8):321-30. PubMed ID: 8984325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic considerations in the management of temporomandibular disorders.
    Haas DA
    J Can Dent Assoc; 1995 Feb; 61(2):105-9, 112-4. PubMed ID: 7600411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined occlusal and pharmacological therapy in the treatment of temporo-mandibular disorders.
    Inchingolo F; Tatullo M; Marrelli M; Inchingolo AM; Tarullo A; Inchingolo AD; Dipalma G; Podo Brunetti S; Tarullo A; Cagiano R
    Eur Rev Med Pharmacol Sci; 2011 Nov; 15(11):1296-300. PubMed ID: 22195362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug therapy for the orofacial and TMD pain patient.
    Ganzberg S
    Tex Dent J; 2000 Jul; 117(7):76-81. PubMed ID: 11858067
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical aspects of craniomandibular disorders. I. Analysis of a sample group of patients and diagnostic classification].
    Capurso U
    Minerva Stomatol; 1996; 45(7-8):311-20. PubMed ID: 8984324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signs of temporomandibular disorders in tinnitus patients and in a population-based group of volunteers: results of the Study of Health in Pomerania.
    Bernhardt O; Gesch D; Schwahn C; Bitter K; Mundt T; Mack F; Kocher T; Meyer G; Hensel E; John U
    J Oral Rehabil; 2004 Apr; 31(4):311-9. PubMed ID: 15089935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical aspects of cranio-mandibular disorders. III. Principles of elective therapy].
    Capurso U
    Minerva Stomatol; 1996; 45(7-8):331-9. PubMed ID: 8984326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of muscular position splint on maxillomandibular realignment].
    Jiao G; Wang Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 Aug; 17(3):254-6. PubMed ID: 12539299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification, causation and treatment of masticatory myogenous pain and dysfunction.
    Clark GT
    Oral Maxillofac Surg Clin North Am; 2008 May; 20(2):145-57, v. PubMed ID: 18343321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy in Temporomandibular Disorders: A Review.
    Ouanounou A; Goldberg M; Haas DA
    J Can Dent Assoc; 2017 Jul; 83():h7. PubMed ID: 29513209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Features and treatment of skeletal class III malocclusion with severe lateral mandibular shift and asymmetric vertical dimension.
    Kondo E
    World J Orthod; 2004; 5(1):9-24. PubMed ID: 15615138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic response of benzodiazepine, orphenadrine citrate and occlusal splint association in TMD pain.
    Rizzatti-Barbosa CM; Martinelli DA; Ambrosano GM; de Albergaria-Barbosa JR
    Cranio; 2003 Apr; 21(2):116-20. PubMed ID: 12723857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical versus systemic diclofenac in the treatment of temporo-mandibular joint dysfunction symptoms.
    Di Rienzo Businco L; Di Rienzo Businco A; D'Emilia M; Lauriello M; Coen Tirelli G
    Acta Otorhinolaryngol Ital; 2004 Oct; 24(5):279-83. PubMed ID: 15871609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical capsaicin-pharmacology and potential role in the treatment of temporomandibular pain.
    Hersh EV; Pertes RA; Ochs HA
    J Clin Dent; 1994; 5(2):54-9. PubMed ID: 7528023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical factors affecting the outcome of occlusal splint therapy of temporomandibular joint disorders.
    Emshoff R
    J Oral Rehabil; 2006 Jun; 33(6):393-401. PubMed ID: 16671984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.